Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorPublished on 01.12.2008
L. Kocsis, T. Bruckdorfer, G. Orosz
Tetrahedron Lett. 2008; 49: 7015-7017; https://doi.org/10.1016/j.tetlet.2008.09.126
Abstract: A novel, ethylene glycol-based protecting group is designed and synthesized for use in solid phase peptide synthesis. Ether and ester type protected amino acids are prepared. The acid stability of the new protecting group showed complete Fmoc/t-Bu compatibility. The new derivatives are tested in solid phase peptide synthesis, with a ‘difficult’ sequence to examine the disruption of peptide aggregation.Graphical abstractAn Fmoc compatible side chain protecting group family is developed, which inhibits peptide chain aggregation. Protected amino acid derivatives can easily be incorporated into existing automated and manual peptide synthesis protocols.